Cilostazol Production Cost Reports

The report provides a detailed analysis essential for establishing a Cilostazol production plant. It encompasses all critical aspects necessary for Cilostazol production, including the cost of Cilostazol production, Cilostazol plant cost, Cilostazol production costs, and the overall Cilostazol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Cilostazol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Cilostazol is a medication that is used to treat intermittent claudication, which is a condition that leads to pain and cramping in the legs, caused by narrowed arteries and reduced blood flow. It works by stopping the enzyme phosphodiesterase III, which increases cyclic AMP levels in blood vessels and platelets, leading to vasodilation and reduced platelet aggregation. This dual action helps improve blood flow and reduce symptoms during walking. It is also used to prevent secondary strokes and to reduce restenosis after vascular interventions.

Its effects include vasodilation, antiplatelet activity, and protective effects against ischemic damage, which makes it useful in managing vascular conditions beyond just leg pain relief. Overall, it improves walking distance and quality of life in patients with peripheral artery disease by enhancing blood circulation and preventing clot formation.

The market for Cilostazol is fuelled by the increasing cases of peripheral artery disease (PAD) and intermittent claudication. The rise in the ageing population and growing cardiovascular conditions because of lifestyle factors, improved diagnostics, and expanding healthcare infrastructure boost its demand.

The greater awareness regarding PAD and demand from hospitals and clinics make it a popular product. The industrial Cilostazol procurement is affected by generic competition after patent expiry and varying regulatory approvals across markets. Also, healthcare reimbursement policies, the presence of alternative antiplatelets, and side effect considerations impact its sourcing strategies. Supply chain reliance on institutional buyers, along with growth in developing markets because of affordable generics, influences its market dynamics.

Raw Material for Cilostazol Production

According to the Cilostazol production plant project report, the key raw materials used in the production of Cilostazol include (1-Cyclohexyl-5-(4-Chlorobutyl)-1,2,3,4-Tetrazole)-(6-Hydroxy-3,4-Dihydroquinolone)-Potassium Carbonate-Sodium Hydroxide-Sodium Sulfite.

Production Process of Cilostazol

The extensive Cilostazol production cost report consists of the following major industrial production process:

1. By Reflux Reaction: The production process of Cilostazol involves a reaction between 1-cyclohexyl-5-(4-chlorobutyl)-1,2,3,4-tetrazole and 6-hydroxy-3,4-dihydroquinolone. This reaction takes place in the presence of potassium carbonate, sodium hydroxide, sodium sulfite, and ethanol as solvents and reagents. The reaction mixture is heated under reflux for several hours, which allows efficient coupling of the tetrazole and hydroxyquinolone components under basic conditions. After initial reflux, water is added, stirred, and the reflux is continued. The mixture is then allowed to separate into aqueous and organic phases. The organic phase is cooled to induce crystallisation, and the crystallised solid is isolated by filtration, washed with ethanol, and dried to get Cilostazol as the final product.

Cilostazol appears as off-white to colourless needle-like crystals with a melting point of around 159-160 degree Celsius. It has a molecular formula of C20H27N5O2, and a molecular weight of around 369.46 g/mol. It is poorly soluble in water but freely soluble in solvents like dimethyl sulfoxide (DMSO), acetic acid, chloroform, and N-methyl-2-pyrrolidone. It has a refractive index of about 1.76 and a predicted pKa around 14.22. Its UV absorption maximum in methanol is at 257 nm. It is chemically stable with a shelf life of up to two years when stored under an inert atmosphere at room temperature, and solutions in DMSO can be stored at -20 degree Celsius for up to two months. All these physical and chemical properties make it useful in the synthesis of pharmaceutical formulations.